"10.1371_journal.pone.0011021","plos one","2010-06-08T00:00:00Z","Peter T Loudon; Eric J Yager; Debbie T Lynch; Amithi Narendran; Cristy Stagnar; Anthony M Franchini; James T Fuller; Phil A White; Julia Nyuandi; Clayton A Wiley; Michael Murphey-Corb; Deborah H Fuller","PowderMed Ltd., Oxford, United Kingdom; Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York, United States of America; Recombiworks, Ltd., Clifton Park, New York, United States of America; Department of Medical Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America; Division of Neuropathology, Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America","Conceived and designed the experiments: PTL EJY DTL MMC DHF. Performed the experiments: EJY DTL AN CS AMF JTF PAW JN CAW DHF. Analyzed the data: PTL EJY DTL AN CS AMF JTF PAW JN CAW MMC DHF. Contributed reagents/materials/analysis tools: PTL JTF PAW MMC. Wrote the paper: PTL EJY DTL MMC DHF.","Peter T. Loudon, Debbie Lynch, and Phil A. White were shareholders and employees of PowderMed, Ltd. at the time the study was performed and are now employees/shareholders of Pfizer which acquired PowderMed Ltd. Pfizer holds patents on the particle-mediated delivery (PMED) technology. James T. Fuller was a consultant for PowderMed at the time the study was performed and contributed experimental effort as an employee of Recombiworks, Ltd. but has no other competing interests. All other authors claim no competing interests. All authors are able to adhere to the PloS ONE policies on sharing data and materials.","2010","06","Peter T Loudon","PTL",12,FALSE,5,10,12,5,TRUE,TRUE,FALSE,0,NA,FALSE
